Consider the Pros and Cons of the ACC/AHA CV Risk Estimator

September 2018

There's increasing debate about how to estimate cardiovascular risk.

We've used the Am Coll of Cardiology/Am Heart Assn CV risk estimator for years...to assess 10-year CV risk in patients withOUT CV disease.

It's mainly been used for statins. Guidelines generally recommend a statin for primary prevention if 10-year CV risk is 7.5% or higher.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote